• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical factors associated with baseline history of atrial fibrillation and subsequent clinical outcomes following initial implantable cardioverter-defibrillator placement.与初始植入式心脏复律除颤器放置后基线心房颤动病史及随后临床结局相关的临床因素。
Pacing Clin Electrophysiol. 2020 Jun;43(6):542-550. doi: 10.1111/pace.13919. Epub 2020 May 2.
2
Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality.植入式心脏复律除颤器患者新检测出的心房颤动是死亡率增加的强烈风险标志物。
Heart Rhythm. 2009 Jan;6(1):2-8. doi: 10.1016/j.hrthm.2008.09.025. Epub 2008 Sep 27.
3
The role of atrial sensing for new-onset atrial arrhythmias diagnosis and management in single-chamber implantable cardioverter-defibrillator recipients: Results from the THINGS registry.单腔植入式心律转复除颤器受者中新发房性心律失常诊断和管理中心房感知的作用:来自 THINGS 注册研究的结果。
J Cardiovasc Electrophysiol. 2020 Apr;31(4):846-853. doi: 10.1111/jce.14396. Epub 2020 Feb 25.
4
Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.在接受植入式心脏复律除颤器治疗的左心室功能不全患者中,持续性心房颤动与恰当的电击和心力衰竭相关。
Am Heart J. 2007 Jan;153(1):120-6. doi: 10.1016/j.ahj.2006.09.010.
5
Impaired left atrial function predicts inappropriate shocks in primary prevention implantable cardioverter-defibrillator candidates.左心房功能受损可预测原发性预防植入式心脏复律除颤器候选者的不适当电击。
J Cardiovasc Electrophysiol. 2017 Jul;28(7):796-805. doi: 10.1111/jce.13234. Epub 2017 Jun 22.
6
Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.心房颤动触发的植入式心脏转复除颤器(ICD)电击与因导线故障引起的不适当电击的比较:对临床实践中预后的不同影响。
J Cardiovasc Electrophysiol. 2012 Jul;23(7):735-40. doi: 10.1111/j.1540-8167.2011.02279.x. Epub 2012 Feb 7.
7
Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.根据电击节律对植入式心脏复律除颤器和心脏再同步治疗除颤器受者电击治疗后的生存情况。节律研究中的 ALTITUDE 生存情况。
J Am Coll Cardiol. 2013 Oct 29;62(18):1674-1679. doi: 10.1016/j.jacc.2013.04.083. Epub 2013 Jun 27.
8
Digitalis Therapy and Risk of Recurrent Ventricular Tachyarrhythmias and ICD Therapies in Atrial Fibrillation and Heart Failure.洋地黄疗法与心房颤动合并心力衰竭患者复发性室性心律失常及植入式心律转复除颤器治疗风险
Cardiology. 2019;142(3):129-140. doi: 10.1159/000497271. Epub 2019 Jun 12.
9
Defibrillation testing and clinical outcomes after implantable cardioverter-defibrillator implantation in patients in atrial fibrillation at the time of implant: An analysis from the SIMPLE trial.在植入时患有心房颤动的患者中进行植入式心脏复律除颤器植入后的除颤测试和临床结果:来自 SIMPLE 试验的分析。
Heart Rhythm. 2019 Jan;16(1):83-90. doi: 10.1016/j.hrthm.2018.07.030. Epub 2018 Jul 29.
10
Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure.胺碘酮或植入式心脏复律除颤器在心房颤动合并心力衰竭患者中的作用。
Am Heart J. 2006 Nov;152(5):974.e7-11. doi: 10.1016/j.ahj.2006.08.012.

本文引用的文献

1
Continuous optimization of cardiac resynchronization therapy reduces atrial fibrillation in heart failure patients: Results of the Adaptive Cardiac Resynchronization Therapy Trial.连续优化心脏再同步治疗可降低心力衰竭患者心房颤动的发生率:适应性心脏再同步治疗试验的结果。
Heart Rhythm. 2017 Dec;14(12):1820-1825. doi: 10.1016/j.hrthm.2017.08.017. Epub 2017 Sep 9.
2
Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction.心房颤动引发心力衰竭,反之亦然:射血分数保留与降低时的时间关联及差异
Circulation. 2016 Feb 2;133(5):484-92. doi: 10.1161/CIRCULATIONAHA.115.018614. Epub 2016 Jan 8.
3
Current trends in the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology member countries: 2015 report from the European Heart Rhythm Association.欧洲心脏病学会成员国心脏植入式电子设备及介入性电生理手术的当前使用趋势:欧洲心律协会2015年报告
Europace. 2015 Aug;17 Suppl 4:iv1-72. doi: 10.1093/europace/euv265.
4
Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial.强化起搏模式对心动过缓患者医疗资源利用及成本的影响:随机MINERVA试验分析
Heart Rhythm. 2015 Jun;12(6):1192-200. doi: 10.1016/j.hrthm.2015.02.017. Epub 2015 Feb 19.
5
Predictors of new onset atrial fibrillation in patients with heart failure.
Int J Cardiol. 2014 Aug 1;175(2):328-32. doi: 10.1016/j.ijcard.2014.05.023. Epub 2014 May 17.
6
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.2014年美国心脏协会/美国心脏病学会/心律学会心房颤动患者管理指南:美国心脏病学会/美国心脏协会实践指南工作组和心律学会的报告
Circulation. 2014 Dec 2;130(23):e199-267. doi: 10.1161/CIR.0000000000000041. Epub 2014 Mar 28.
7
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会基金会/美国心脏协会实践指南工作组关于心力衰竭管理的指南:美国心脏病学会基金会/美国心脏协会报告
J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239. doi: 10.1016/j.jacc.2013.05.019. Epub 2013 Jun 5.
8
Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches.植入式心脏复律除颤器电击:流行病学、结果和治疗方法。
JAMA Intern Med. 2013 May 27;173(10):859-65. doi: 10.1001/jamainternmed.2013.428.
9
ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance.ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013年植入式心脏复律除颤器和心脏再同步治疗的合理使用标准:美国心脏病学基金会合理使用标准工作组、心律协会、美国心脏协会、美国超声心动图学会、美国心力衰竭学会、心血管造影和介入学会、心血管计算机断层扫描学会以及心血管磁共振学会的报告
J Am Coll Cardiol. 2013 Mar 26;61(12):1318-68. doi: 10.1016/j.jacc.2012.12.017. Epub 2013 Mar 1.
10
The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011.《国家国际疾病分类登记报告:2.1版,涵盖2010年和2011年的导联及儿科内容》
Heart Rhythm. 2013 Apr;10(4):e59-65. doi: 10.1016/j.hrthm.2013.01.035. Epub 2013 Feb 9.

与初始植入式心脏复律除颤器放置后基线心房颤动病史及随后临床结局相关的临床因素。

Clinical factors associated with baseline history of atrial fibrillation and subsequent clinical outcomes following initial implantable cardioverter-defibrillator placement.

机构信息

Cardiac Electrophysiology Section, Division of Cardiology, Department of Medicine, University of California, San Diego, California.

出版信息

Pacing Clin Electrophysiol. 2020 Jun;43(6):542-550. doi: 10.1111/pace.13919. Epub 2020 May 2.

DOI:10.1111/pace.13919
PMID:32297348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7299732/
Abstract

BACKGROUND

Atrial fibrillation (AF) is frequently present in patients with heart failure (HF) and an implantable cardioverter-defibrillator (ICD). This study aims to identify clinical factors associated with a baseline history of AF in ICD recipients, and compares subsequent clinical outcomes in those with and without a baseline history of AF.

METHODS

We studied 566 consecutive first-time ICD recipients at an academic center between 2011 and 2018. Logistic regression multivariable analyses were used to identify clinical factors associated with a baseline history of AF at the time of ICD implant. Cox-proportional hazard regression models were constructed for multivariate analysis to examine associations between a baseline history of AF with subsequent clinical outcomes, including ICD therapies, HF readmission, and all-cause mortality.

RESULTS

Of all patients, 201 (36%) had a baseline history of AF at the time of ICD implant. In multivariate analyses, clinical factors associated with a baseline history of AF included hypertension, valvular heart disease, body weight, PR interval, and serum creatinine level. After multivariate adjustment for potential confounders, a baseline history of AF was associated with an increased risk of anti-tachycardia pacing (HR = 1.84, 95% CI = 1.19-2.85, P = .006), appropriate ICD shocks (HR = 1.80, 95% CI = 1.05-3.09, P = .032), and inappropriate ICD shocks (HR = 3.72, 95% CI = 1.7-7.77, P = .0001), but not other adverse outcomes.

CONCLUSION

Among first-time ICD recipients, specific clinical characteristics were associated with a baseline history of AF at the time of ICD implant. After adjustment for potential confounders, a baseline history of AF was associated with a higher risk of all ICD therapies in follow-up.

摘要

背景

心房颤动(AF)在心力衰竭(HF)和植入式心脏复律除颤器(ICD)患者中经常出现。本研究旨在确定与 ICD 接受者基线 AF 病史相关的临床因素,并比较有和无基线 AF 病史患者的后续临床结局。

方法

我们研究了 2011 年至 2018 年间在学术中心接受首次 ICD 植入的 566 例连续患者。使用逻辑回归多变量分析来确定与 ICD 植入时基线 AF 病史相关的临床因素。构建 Cox 比例风险回归模型进行多变量分析,以研究基线 AF 病史与随后的临床结局(包括 ICD 治疗、HF 再入院和全因死亡率)之间的关联。

结果

所有患者中,201 例(36%)在 ICD 植入时存在基线 AF 病史。在多变量分析中,与基线 AF 病史相关的临床因素包括高血压、瓣膜性心脏病、体重、PR 间期和血清肌酐水平。在对潜在混杂因素进行多变量调整后,基线 AF 病史与抗心动过速起搏的风险增加相关(HR=1.84,95%CI=1.19-2.85,P=0.006),适当的 ICD 电击(HR=1.80,95%CI=1.05-3.09,P=0.032)和不适当的 ICD 电击(HR=3.72,95%CI=1.7-7.77,P=0.0001),但与其他不良结局无关。

结论

在首次接受 ICD 植入的患者中,特定的临床特征与 ICD 植入时的基线 AF 病史相关。在调整潜在混杂因素后,基线 AF 病史与随访中所有 ICD 治疗的风险增加相关。